This report contains market size and forecasts of Anxiolytic Drugs in Global, including the following market information:
Global Anxiolytic Drugs Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Anxiolytic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Tablets Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anxiolytic Drugs include Pfizer, Johnson & Johnson, AstraZeneca, Eli Lilly, Novartis, Bristol Myers Squibb, GSK Plc, Mylan (Viatris) and Allergan, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anxiolytic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anxiolytic Drugs Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Anxiolytic Drugs Market Segment Percentages, by Type, 2022 (%)
Tablets
Capsules
Other
Global Anxiolytic Drugs Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Anxiolytic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Other
Global Anxiolytic Drugs Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Anxiolytic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anxiolytic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anxiolytic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
AstraZeneca
Eli Lilly
Novartis
Bristol Myers Squibb
GSK Plc
Mylan (Viatris)
Allergan
Takeda Pharmaceutical
Bausch Health
Zhejiang Huahai
Chengdu Kanghong Pharmaceutical
Beijing Fuyuan Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anxiolytic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anxiolytic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anxiolytic Drugs Overall Market Size
2.1 Global Anxiolytic Drugs Market Size: 2022 VS 2030
2.2 Global Anxiolytic Drugs Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anxiolytic Drugs Players in Global Market
3.2 Top Global Anxiolytic Drugs Companies Ranked by Revenue
3.3 Global Anxiolytic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anxiolytic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anxiolytic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anxiolytic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anxiolytic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anxiolytic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Anxiolytic Drugs Market Size Markets, 2022 & 2030
4.1.2 Tablets
4.1.3 Capsules
4.1.4 Other
4.2 By Type - Global Anxiolytic Drugs Revenue & Forecasts
4.2.1 By Type - Global Anxiolytic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anxiolytic Drugs Revenue, 2023-2030
4.2.3 By Type - Global Anxiolytic Drugs Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anxiolytic Drugs Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Anxiolytic Drugs Revenue & Forecasts
5.2.1 By Application - Global Anxiolytic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anxiolytic Drugs Revenue, 2023-2030
5.2.3 By Application - Global Anxiolytic Drugs Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Anxiolytic Drugs Market Size, 2022 & 2030
6.2 By Region - Global Anxiolytic Drugs Revenue & Forecasts
6.2.1 By Region - Global Anxiolytic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anxiolytic Drugs Revenue, 2023-2030
6.2.3 By Region - Global Anxiolytic Drugs Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Anxiolytic Drugs Revenue, 2018-2030
6.3.2 US Anxiolytic Drugs Market Size, 2018-2030
6.3.3 Canada Anxiolytic Drugs Market Size, 2018-2030
6.3.4 Mexico Anxiolytic Drugs Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Anxiolytic Drugs Revenue, 2018-2030
6.4.2 Germany Anxiolytic Drugs Market Size, 2018-2030
6.4.3 France Anxiolytic Drugs Market Size, 2018-2030
6.4.4 U.K. Anxiolytic Drugs Market Size, 2018-2030
6.4.5 Italy Anxiolytic Drugs Market Size, 2018-2030
6.4.6 Russia Anxiolytic Drugs Market Size, 2018-2030
6.4.7 Nordic Countries Anxiolytic Drugs Market Size, 2018-2030
6.4.8 Benelux Anxiolytic Drugs Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Anxiolytic Drugs Revenue, 2018-2030
6.5.2 China Anxiolytic Drugs Market Size, 2018-2030
6.5.3 Japan Anxiolytic Drugs Market Size, 2018-2030
6.5.4 South Korea Anxiolytic Drugs Market Size, 2018-2030
6.5.5 Southeast Asia Anxiolytic Drugs Market Size, 2018-2030
6.5.6 India Anxiolytic Drugs Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Anxiolytic Drugs Revenue, 2018-2030
6.6.2 Brazil Anxiolytic Drugs Market Size, 2018-2030
6.6.3 Argentina Anxiolytic Drugs Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anxiolytic Drugs Revenue, 2018-2030
6.7.2 Turkey Anxiolytic Drugs Market Size, 2018-2030
6.7.3 Israel Anxiolytic Drugs Market Size, 2018-2030
6.7.4 Saudi Arabia Anxiolytic Drugs Market Size, 2018-2030
6.7.5 UAE Anxiolytic Drugs Market Size, 2018-2030
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Anxiolytic Drugs Major Product Offerings
7.1.4 Pfizer Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Anxiolytic Drugs Major Product Offerings
7.2.4 Johnson & Johnson Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Anxiolytic Drugs Major Product Offerings
7.3.4 AstraZeneca Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News
7.4 Eli Lilly
7.4.1 Eli Lilly Corporate Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Anxiolytic Drugs Major Product Offerings
7.4.4 Eli Lilly Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Anxiolytic Drugs Major Product Offerings
7.5.4 Novartis Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Corporate Summary
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Anxiolytic Drugs Major Product Offerings
7.6.4 Bristol Myers Squibb Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.6.5 Bristol Myers Squibb Key News
7.7 GSK Plc
7.7.1 GSK Plc Corporate Summary
7.7.2 GSK Plc Business Overview
7.7.3 GSK Plc Anxiolytic Drugs Major Product Offerings
7.7.4 GSK Plc Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.7.5 GSK Plc Key News
7.8 Mylan (Viatris)
7.8.1 Mylan (Viatris) Corporate Summary
7.8.2 Mylan (Viatris) Business Overview
7.8.3 Mylan (Viatris) Anxiolytic Drugs Major Product Offerings
7.8.4 Mylan (Viatris) Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.8.5 Mylan (Viatris) Key News
7.9 Allergan
7.9.1 Allergan Corporate Summary
7.9.2 Allergan Business Overview
7.9.3 Allergan Anxiolytic Drugs Major Product Offerings
7.9.4 Allergan Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.9.5 Allergan Key News
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Corporate Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical Anxiolytic Drugs Major Product Offerings
7.10.4 Takeda Pharmaceutical Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.10.5 Takeda Pharmaceutical Key News
7.11 Bausch Health
7.11.1 Bausch Health Corporate Summary
7.11.2 Bausch Health Business Overview
7.11.3 Bausch Health Anxiolytic Drugs Major Product Offerings
7.11.4 Bausch Health Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.11.5 Bausch Health Key News
7.12 Zhejiang Huahai
7.12.1 Zhejiang Huahai Corporate Summary
7.12.2 Zhejiang Huahai Business Overview
7.12.3 Zhejiang Huahai Anxiolytic Drugs Major Product Offerings
7.12.4 Zhejiang Huahai Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.12.5 Zhejiang Huahai Key News
7.13 Chengdu Kanghong Pharmaceutical
7.13.1 Chengdu Kanghong Pharmaceutical Corporate Summary
7.13.2 Chengdu Kanghong Pharmaceutical Business Overview
7.13.3 Chengdu Kanghong Pharmaceutical Anxiolytic Drugs Major Product Offerings
7.13.4 Chengdu Kanghong Pharmaceutical Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.13.5 Chengdu Kanghong Pharmaceutical Key News
7.14 Beijing Fuyuan Pharmaceutical
7.14.1 Beijing Fuyuan Pharmaceutical Corporate Summary
7.14.2 Beijing Fuyuan Pharmaceutical Business Overview
7.14.3 Beijing Fuyuan Pharmaceutical Anxiolytic Drugs Major Product Offerings
7.14.4 Beijing Fuyuan Pharmaceutical Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.14.5 Beijing Fuyuan Pharmaceutical Key News
7.15 Zhejiang Jianfeng Pharmaceutical
7.15.1 Zhejiang Jianfeng Pharmaceutical Corporate Summary
7.15.2 Zhejiang Jianfeng Pharmaceutical Business Overview
7.15.3 Zhejiang Jianfeng Pharmaceutical Anxiolytic Drugs Major Product Offerings
7.15.4 Zhejiang Jianfeng Pharmaceutical Anxiolytic Drugs Revenue in Global Market (2018-2023)
7.15.5 Zhejiang Jianfeng Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anxiolytic Drugs Market Opportunities & Trends in Global Market
Table 2. Anxiolytic Drugs Market Drivers in Global Market
Table 3. Anxiolytic Drugs Market Restraints in Global Market
Table 4. Key Players of Anxiolytic Drugs in Global Market
Table 5. Top Anxiolytic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anxiolytic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anxiolytic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anxiolytic Drugs Product Type
Table 9. List of Global Tier 1 Anxiolytic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anxiolytic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anxiolytic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Anxiolytic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anxiolytic Drugs Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Anxiolytic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Anxiolytic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anxiolytic Drugs Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Anxiolytic Drugs Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Anxiolytic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anxiolytic Drugs Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Anxiolytic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anxiolytic Drugs Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Anxiolytic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anxiolytic Drugs Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Anxiolytic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anxiolytic Drugs Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Anxiolytic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anxiolytic Drugs Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Anxiolytic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anxiolytic Drugs Revenue, (US$, Mn), 2023-2030
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Anxiolytic Drugs Product Offerings
Table 32. Pfizer Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Anxiolytic Drugs Product Offerings
Table 35. Johnson & Johnson Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Anxiolytic Drugs Product Offerings
Table 38. AstraZeneca Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 39. Eli Lilly Corporate Summary
Table 40. Eli Lilly Anxiolytic Drugs Product Offerings
Table 41. Eli Lilly Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 42. Novartis Corporate Summary
Table 43. Novartis Anxiolytic Drugs Product Offerings
Table 44. Novartis Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Bristol Myers Squibb Corporate Summary
Table 46. Bristol Myers Squibb Anxiolytic Drugs Product Offerings
Table 47. Bristol Myers Squibb Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 48. GSK Plc Corporate Summary
Table 49. GSK Plc Anxiolytic Drugs Product Offerings
Table 50. GSK Plc Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 51. Mylan (Viatris) Corporate Summary
Table 52. Mylan (Viatris) Anxiolytic Drugs Product Offerings
Table 53. Mylan (Viatris) Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Allergan Corporate Summary
Table 55. Allergan Anxiolytic Drugs Product Offerings
Table 56. Allergan Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 57. Takeda Pharmaceutical Corporate Summary
Table 58. Takeda Pharmaceutical Anxiolytic Drugs Product Offerings
Table 59. Takeda Pharmaceutical Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 60. Bausch Health Corporate Summary
Table 61. Bausch Health Anxiolytic Drugs Product Offerings
Table 62. Bausch Health Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 63. Zhejiang Huahai Corporate Summary
Table 64. Zhejiang Huahai Anxiolytic Drugs Product Offerings
Table 65. Zhejiang Huahai Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 66. Chengdu Kanghong Pharmaceutical Corporate Summary
Table 67. Chengdu Kanghong Pharmaceutical Anxiolytic Drugs Product Offerings
Table 68. Chengdu Kanghong Pharmaceutical Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 69. Beijing Fuyuan Pharmaceutical Corporate Summary
Table 70. Beijing Fuyuan Pharmaceutical Anxiolytic Drugs Product Offerings
Table 71. Beijing Fuyuan Pharmaceutical Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
Table 72. Zhejiang Jianfeng Pharmaceutical Corporate Summary
Table 73. Zhejiang Jianfeng Pharmaceutical Anxiolytic Drugs Product Offerings
Table 74. Zhejiang Jianfeng Pharmaceutical Anxiolytic Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Anxiolytic Drugs Segment by Type in 2022
Figure 2. Anxiolytic Drugs Segment by Application in 2022
Figure 3. Global Anxiolytic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anxiolytic Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Anxiolytic Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anxiolytic Drugs Revenue in 2022
Figure 8. By Type - Global Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 9. By Application - Global Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 10. By Region - Global Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 11. By Country - North America Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 12. US Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 16. Germany Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 17. France Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 24. China Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 28. India Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 30. Brazil Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Anxiolytic Drugs Revenue Market Share, 2018-2030
Figure 33. Turkey Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Anxiolytic Drugs Revenue, (US$, Mn), 2018-2030
Figure 37. Pfizer Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Johnson & Johnson Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. AstraZeneca Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Eli Lilly Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Novartis Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bristol Myers Squibb Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GSK Plc Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mylan (Viatris) Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Allergan Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Takeda Pharmaceutical Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Bausch Health Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Zhejiang Huahai Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Chengdu Kanghong Pharmaceutical Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Beijing Fuyuan Pharmaceutical Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Zhejiang Jianfeng Pharmaceutical Anxiolytic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
